Clinical Diagnostics Market, By Sample Type (Tissue/Biopsy, Blood/Plasma/Serum, Urine, and Saliva), By Test, By Product, By Technology, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
AV5024
|
Published Date
April 2026
|
Pages
397
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Clinical Diagnostics Market size was valued at US$ 122,406.11 Million in 2025, expanding at a CAGR of 7.01% from 2026 to 2033.
Clinical diagnostics is a cornerstone of modern healthcare, enabling medical professionals to detect, monitor, and manage diseases using advanced diagnostic technologies rather than relying solely on traditional methods. These solutions reduce diagnostic effort and turnaround time while enhancing accuracy, patient safety, and treatment outcomes. By providing timely and reliable test results, clinical diagnostics supports a wide range of medical conditions and contributes to overall healthcare efficiency. Widely implemented in hospitals, laboratories, and point-of-care settings, it remains an essential—though often underrecognized—component of contemporary medical practice.
The clinical diagnostics market is experiencing increasing demand for laboratory automation, which enhances operational efficiency and minimizes human error. Automated systems accelerate test processing, improve accuracy, and streamline workflows, making faster and more reliable diagnoses possible. According to the International Diabetes Federation (IDF), approximately 537million adults aged 20–79 were living with diabetes in 2021, with projections rising to 643million by 2030 and 783million by 2045. This expanding patient population is expected to further drive global adoption of advanced diagnostic technologies and automated testing solutions.
Clinical Diagnostics Market- Market Dynamics
Rising Incidence of Chronic Diseases to Fuel Market Growth
The rising prevalence of chronic diseases such as cancer, cardiovascular disorders, diabetes, and respiratory conditions is driving increased demand for clinical diagnostic services. Accurate and timely diagnosis is crucial for effective disease management. An aging global population, combined with lifestyle-related risk factors, is contributing to higher incidence rates, creating a growing need for diagnostic tests to detect, monitor, and guide treatment strategies. For example, according to the WHO, approximately 400,000 children and adolescents aged 0–19 are diagnosed with cancer each year, with nearly 90% of cases occurring in low- and middle-income countries where access to effective treatment is limited and survival rates remain below 30%, compared with over 80% in high-income countries. The WHO’s Global Initiative for Childhood Cancer aims to increase survival rates to 60% by 2030, potentially saving 1million young lives, highlighting the vital role of advanced diagnostic services in improving healthcare outcomes and reducing disparities worldwide.
Clinical Diagnostics Market- Segmentation Analysis:
The Global Clinical Diagnostics Market is segmented on the basis of Sample Type, Test, Product, Technology, End User, and Region.
The blood, plasma, and serum segment holds a prominent share in the clinical diagnostics market by sample type, owing to its widespread use in both routine and specialized testing. Blood-based samples provide high accuracy and reliability for detecting a wide range of conditions, including infections, metabolic disorders, and chronic diseases, making them a preferred choice in clinical laboratories. For example, according to a 2024 PubMed study (US Government), the global burden of metabolic diseases has increased significantly over the past three decades, with hypertension accounting for roughly 226million disability-adjusted life years (DALYs) and type 2 diabetes contributing around 75million DALYs. This 1.6–3× rise in metabolic disease burden underscores a growing global health challenge and reinforces the reliance on blood-based diagnostics for effective disease detection and monitoring.
By test type, the clinical diagnostics market is segmented into lipid panels, liver panels, renal panels, complete blood count (CBC), electrolyte testing, infectious disease testing, oncology and tumor marker testing, and companion diagnostics. The complete blood count (CBC) segment holds a major market share and is projected to continue growing over the forecast period. Its strong position is attributed to its routine use in health check-ups, ability to detect a broad spectrum of conditions, cost-effectiveness, and accessibility across healthcare settings. For instance, according to Healthy People 2030, only 5.3% of U.S. adults aged 35 and older received all recommended high-priority evidence-based clinical preventive services in 2020—a figure below the Healthy People 2030 target of 11.5% and the 2015 baseline of 8.5%. Many individuals miss essential preventive services, such as screenings, dental care, and vaccinations, due to cost, limited access, or low awareness. This growing focus on preventive healthcare and routine diagnostics is expected to sustain demand for CBC testing in the clinical diagnostics market.
Clinical Diagnostics Market- Geographical Insights
North America is expected to retain a significant share of the global clinical diagnostics market throughout the forecast period. Revenue growth in the region is driven by the rising prevalence of blood-related and chronic conditions, including infectious diseases, cancers, and deficiency disorders. Additionally, new product approvals, ongoing R&D initiatives by key manufacturers, and supportive government policies are fueling market expansion. For example, in 2024, the Centers for Medicare & Medicaid Services (CMS) reported that U.S. national healthcare spending reached approximately $5.3trillion, representing a 7.2% increase over 2023. Healthcare expenditures accounted for 18.0% of the U.S. GDP, up from 17.7% the previous year, with hospital care and physician services among the fastest-growing categories. This demonstrates sustained demand for advanced clinical diagnostics solutions across the U.S. healthcare sector.
The Asia-Pacific clinical diagnostics market is also projected to witness substantial growth during the forecast period. The region faces a rising prevalence of chronic and non-communicable diseases, including cardiovascular diseases (CVD), diabetes, cancer, and chronic respiratory disorders. According to the World Heart Federation, CVDs are the leading cause of death in Asia-Pacific, accounting for nearly 40% of all fatalities. Additionally, a 2022 report by the EU-ASEAN Business Council, Transforming Diagnostics Access, highlights challenges and opportunities in improving access to diagnostic services, particularly in low- and middle-income countries (LMICs). These trends underscore the increasing demand for advanced clinical diagnostic solutions across Asia-Pacific’s healthcare landscape.
China & Japan Clinical Diagnostics Market- Country Insights
China’s clinical diagnostics market is being driven by rising per capita income, which is increasing the adoption of diagnostic and therapeutic products, along with government initiatives aimed at strengthening healthcare infrastructure. For instance, in May 2022, Berry Oncology, a Chinese company specializing in genetic testing and early tumor detection, announced plans to launch an early cancer screening product capable of detecting six common tumor types simultaneously. The technology leverages the company’s proprietary HIFI platform, with future plans targeting the identification of more than 20 tumor types from a single blood sample, aiming to enhance screening accuracy and early diagnosis.
Japan also holds a prominent position in the clinical diagnostics market, supported by established companies such as Sysmex Corporation, Sekisui Medical Co., Ltd., and Morimoto Pharma, as well as ongoing advancements in molecular and clinical diagnostic technologies. For example, in June 2022, Sysmex launched its XR-series, a flagship solution that integrates sample sorting, archiving, and automated quality transport within a single device, improving workflow efficiency in diagnostic laboratories. This innovation has garnered attention from government agencies, academic institutions, and research centers, reinforcing Japan’s steady growth and technological leadership in the clinical diagnostics sector.
Clinical Diagnostics Market- Competitive Landscape:
The global clinical diagnostics market is moderately fragmented, with major players including Abbott, Beckman Coulter, Inc., Siemens Healthineers, Danaher, and F.Hoffmann-La Roche Ltd., alongside numerous regional laboratories and specialized service providers. Competition is driven by factors such as technological innovation, comprehensive product portfolios, automation, test accuracy, regulatory approvals, digital integration, and service network capabilities. Emerging trends in the market include increased adoption of molecular diagnostics and next-generation sequencing (NGS), AI-driven laboratory workflows, and the expansion of point-of-care and decentralized testing solutions. For example, in May2024, Danaher partnered with Johns Hopkins University to develop new diagnostic methods for traumatic brain injury, with researchers evaluating novel blood-based biomarkers using Beckman Coulter’s highly sensitive technologies.
Recent Developments:
- In March2026, Siemens Healthineers expanded its diagnostics offerings with advanced Atellica-based biomarker assays for brain health research, enabling high-sensitivity, blood-based testing and supporting faster, minimally invasive workflows through automated analyzer platforms.
- In April2025, Eurofins Scientific acquired SYNLAB’s clinical diagnostics operations in Spain, significantly enhancing its laboratory network, expanding molecular diagnostics capabilities, and increasing its capacity to serve over 10million patients annually.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CLINICAL DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott
- bioMérieux SA
- QuidelOrtho Corporation
- Siemens Healthineers AG
- Bio-Rad Laboratories, Inc.
- Qiagen
- Sysmex Corporation
- Charles River Laboratories
- Quest Diagnostics Incorporated
- Agilent Technologies, Inc.
- Danaher Corporation
- BD (Becton Dickinson)
- F. Hoffmann-La Roche Ltd / Roche Diagnostics
- Thermo Fisher Scientific
- Hologic
- Ortho Clinical Diagnostics
- NeoGenomics, Inc.
- Owkin
- Prenetics Global Limited
- Newfoundland Diagnostics
- Novogenia GmbH
- Nutromics
- Others
GLOBAL CLINICAL DIAGNOSTICS MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2020 - 2033
- Tissue/Biopsy
- Blood/Plasma/Serum
- Urine
- Saliva
- Other Specimens
GLOBAL CLINICAL DIAGNOSTICS MARKET, BY TEST- MARKET ANALYSIS, 2020 - 2033
- Complete Blood Count (CBC)
- Electrolyte Testing
- Lipid Panel
- Liver Panel
- Renal Panel
- Infectious Disease Testing
- Oncology & Tumor Marker Testing
- Companion Diagnostics
- Other Tests
GLOBAL CLINICAL DIAGNOSTICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Reagents & Kits
- Instruments/Analyzers
- DataManagement Software & Services
GLOBAL CLINICAL DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Molecular Diagnostics
- Immunoassay & Immunochemistry
- Clinical Chemistry
- Hematology
- Coagulation & Hemostasis
- Microbiology
- Urinalysis
- Others (e.g., Mass Spectrometry, Flow Cytometry)
GLOBAL CLINICAL DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- PointofCare Settings
- Hospital Laboratories
- Physician Office Laboratories
- Independent Diagnostic Laboratories
- Other End Users
GLOBAL CLINICAL DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Clinical Diagnostics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Clinical Diagnostics Market Snippet by Sample Type
2.1.2. Clinical Diagnostics Market Snippet by Test
2.1.3. Clinical Diagnostics Market Snippet by Product
2.1.4. Clinical Diagnostics Market Snippet by Technology
2.1.5. Clinical Diagnostics Market Snippet by End User
2.1.6. Clinical Diagnostics Market Snippet by Country
2.1.7. Clinical Diagnostics Market Snippet by Region
2.2. Competitive Insights
3. Clinical Diagnostics Key Market Trends
3.1. Clinical Diagnostics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Clinical Diagnostics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Clinical Diagnostics Market Opportunities
3.4. Clinical Diagnostics Market Future Trends
4. Clinical Diagnostics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Clinical Diagnostics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Clinical Diagnostics Market Landscape
6.1. Clinical Diagnostics Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Clinical Diagnostics Market – By Sample Type
7.1. Overview
7.1.1. Segment Share Analysis, By Sample Type, 2025 & 2033 (%)
7.1.2. Tissue/Biopsy
7.1.3. Blood/Plasma/Serum
7.1.4. Urine
7.1.5. Saliva
7.1.6. Other Specimens
8. Clinical Diagnostics Market – By Test
8.1. Overview
8.1.1. Segment Share Analysis, By Test, 2025 & 2033 (%)
8.1.2. Complete Blood Count (CBC)
8.1.3. Electrolyte Testing
8.1.4. Lipid Panel
8.1.5. Liver Panel
8.1.6. Renal Panel
8.1.7. Infectious Disease Testing
8.1.8. Oncology & Tumor Marker Testing
8.1.9. Companion Diagnostics
8.1.10. Other Tests
9. Clinical Diagnostics Market – By Product
9.1. Overview
9.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
9.1.2. Reagents & Kits
9.1.3. Instruments/Analyzers
9.1.4. DataManagement Software & Services
10. Clinical Diagnostics Market – By Technology
10.1. Overview
10.1.1. Segment Share Analysis, By Test, 2025 & 2033 (%)
10.1.2. Molecular Diagnostics
10.1.3. Immunoassay & Immunochemistry
10.1.4. Clinical Chemistry
10.1.5. Hematology
10.1.6. Coagulation & Hemostasis
10.1.7. Microbiology
10.1.8. Urinalysis
10.1.9. Others (e.g., Mass Spectrometry, Flow Cytometry)
11. Clinical Diagnostics Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
11.1.2. PointofCare Settings
11.1.3. Hospital Laboratories
11.1.4. Physician Office Laboratories
11.1.5. Independent Diagnostic Laboratories
11.1.6. Other End Users
12. Clinical Diagnostics Market – By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
12.2. North America
12.2.1. Overview
12.2.2. Clinical Diagnostics Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.2.4. North America Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.2.5. North America Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.2.6. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.2.7. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Clinical Diagnostics Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Clinical Diagnostics Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Clinical Diagnostics Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Clinical Diagnostics Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Sample Type, 2020 - 2033 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Test, 2020 - 2033 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
13. Key Vendor Analysis- Clinical Diagnostics Industry
13.1. Competitive Benchmarking
13.1.1. Competitive Dashboard
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Abbott
13.2.2. bioMérieux SA
13.2.3. QuidelOrtho Corporation
13.2.4. Siemens Healthineers AG
13.2.5. Bio-Rad Laboratories, Inc.
13.2.6. Qiagen
13.2.7. Sysmex Corporation
13.2.8. Charles River Laboratories
13.2.9. Quest Diagnostics Incorporated
13.2.10. Agilent Technologies, Inc.
13.2.11. Danaher Corporation
13.2.12. BD (Becton Dickinson)
13.2.13. F. Hoffmann-La Roche Ltd / Roche Diagnostics
13.2.14. Thermo Fisher Scientific
13.2.15. Hologic
13.2.16. Ortho Clinical Diagnostics
13.2.17. NeoGenomics, Inc.
13.2.18. Owkin
13.2.19. Prenetics Global Limited
13.2.20. Newfoundland Diagnostics
13.2.21. Novogenia GmbH
13.2.22. Nutromics
13.2.23. Others
14. 360 Degree AnalystView
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CLINICAL DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott
- bioMérieux SA
- QuidelOrtho Corporation
- Siemens Healthineers AG
- Bio-Rad Laboratories, Inc.
- Qiagen
- Sysmex Corporation
- Charles River Laboratories
- Quest Diagnostics Incorporated
- Agilent Technologies, Inc.
- Danaher Corporation
- BD (Becton Dickinson)
- F. Hoffmann-La Roche Ltd / Roche Diagnostics
- Thermo Fisher Scientific
- Hologic
- Ortho Clinical Diagnostics
- NeoGenomics, Inc.
- Owkin
- Prenetics Global Limited
- Newfoundland Diagnostics
- Novogenia GmbH
- Nutromics
- Others
GLOBAL CLINICAL DIAGNOSTICS MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2020 - 2033
- Tissue/Biopsy
- Blood/Plasma/Serum
- Urine
- Saliva
- Other Specimens
GLOBAL CLINICAL DIAGNOSTICS MARKET, BY TEST- MARKET ANALYSIS, 2020 - 2033
- Complete Blood Count (CBC)
- Electrolyte Testing
- Lipid Panel
- Liver Panel
- Renal Panel
- Infectious Disease Testing
- Oncology & Tumor Marker Testing
- Companion Diagnostics
- Other Tests
GLOBAL CLINICAL DIAGNOSTICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Reagents & Kits
- Instruments/Analyzers
- DataManagement Software & Services
GLOBAL CLINICAL DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033
- Molecular Diagnostics
- Immunoassay & Immunochemistry
- Clinical Chemistry
- Hematology
- Coagulation & Hemostasis
- Microbiology
- Urinalysis
- Others (e.g., Mass Spectrometry, Flow Cytometry)
GLOBAL CLINICAL DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- PointofCare Settings
- Hospital Laboratories
- Physician Office Laboratories
- Independent Diagnostic Laboratories
- Other End Users
GLOBAL CLINICAL DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
